HUM-MOLGEN events: CHI's MOLECULAR MEDICINE MARKETPLACE: Genomic Drug Discovery, Business Strategies, Target Driven Chemistry, Strategic Biocomputing

HUM-MOLGEN -> Events -> Meetings and Conferences

CHI's MOLECULAR MEDICINE MARKETPLACE: Genomic Drug Discovery, Business Strategies, Target Driven Chemistry, Strategic Biocomputing

July 23, 2002

Biotechnology

Cambridge Healthtech Institute, Santa Clara Convention Center, Santa Clara, California
March 17-21, 2003

Step into the Future of Drug Discovery with CHI
Leaders in Strategic Thinking and Innovation
As the pharmaceutical industry moves into the post-genomic era, a multi-disciplinary strategy is needed to advance drug development. To offer a more comprehensive overview of the pharmaceutical R&D process, CHI has expanded the Genome Tri-Conference this year to include tracks that will cover Business Strategies, Target-Driven Chemistry, and Strategic Biocomputing in addition to Genomic Drug Discovery. The Molecular Medicine Marketplace conference will provide a forum for researchers and executives to exchange knowledge and determine the strategy to succeed in this changing R&D environment.

Organized by:

CHI

Invited Speakers:

Dr. Tim Hoey, Tularik Inc.
Dr. Charles DeLisi, Boston University
Dr. Dalia Cohen, Novartis Pharmaceuticals
Dr. Geoffrey Duyk, Exelixis Pharmaceuticals
Dr. Christopher Lipinski, Pfizer Global Research and Development
Dr. David Cox, Perlegen Sciences
Sir Tom L. Blundell, University of Cambridge

Deadline for Abstracts:

Poster Abstracts: January 17, 2003

Registration:

Available On-line

E-mail:

eeskedal@healthtech.com

Posted by:

Elaine Eskedal

Host:

wks249.healthtech.com